IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

被引:2186
作者
MECHOULAM, R
BENSHABAT, S
HANUS, L
LIGUMSKY, M
KAMINSKI, NE
SCHATZ, AR
GOPHER, A
ALMOG, S
MARTIN, BR
COMPTON, DR
PERTWEE, RG
GRIFFIN, G
BAYEWITCH, M
BARG, J
VOGEL, Z
机构
[1] MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824
[2] CHAIM SHEBA MED CTR,INST CLIN PHARMACOL & TOXICOL,IL-52621 TEL HASHOMER,ISRAEL
[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
[4] UNIV ABERDEEN,MARISCHAL COLL,DEPT BIOMED SCI,ABERDEEN AB9 1AS,SCOTLAND
[5] WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL
基金
英国惠康基金;
关键词
2-ARACHIDONYL GLYCEROL; ANAND AMIDE; TETRAHYDROCANNABINOL; ARACHIDONYLETHANOLAMIDE; IMMUNE SYSTEM; TRANSFECTION; MOUSE BEHAVIOR; ADENYLATE CYCLASE INHIBITION;
D O I
10.1016/0006-2952(95)00109-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl). Its structure was determined by mass spectrometry and by direct comparison with a synthetic sample. 2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2-the two cannabinoid receptors identified thus far-with K-i values of 472 +/- 55 and 1400 +/- 172 nM, respectively. In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at the potency level of Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Upon intravenous administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, reduction of spontaneous activity, and lowering of the rectal temperature. 2-Ara-Gl also shares the ability of Delta(9)-THC to inhibit electrically evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Delta(9)-THC.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 37 条
  • [1] CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES
    BOUABOULA, M
    RINALDI, M
    CARAYON, P
    CARILLON, C
    DELPECH, B
    SHIRE, D
    LEFUR, G
    CASELLAS, P
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01): : 173 - 180
  • [2] CABRAL GA, 1991, ADV EXP MED BIOL, V288, P93
  • [3] EFFECTS OF ANANDAMIDE ON CANNABINOID RECEPTORS IN RAT-BRAIN MEMBRANES
    CHILDERS, SR
    SEXTON, T
    ROY, MB
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (04) : 711 - 715
  • [4] COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218
  • [5] COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201
  • [6] ENZYMATIC-SYNTHESIS AND DEGRADATION OF ANANDAMIDE, A CANNABINOID RECEPTOR AGONIST
    DEUTSCH, DG
    CHIN, SA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 46 (05) : 791 - 796
  • [7] DEVANE WA, 1988, MOL PHARMACOL, V34, P605
  • [8] ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR
    DEVANE, WA
    HANUS, L
    BREUER, A
    PERTWEE, RG
    STEVENSON, LA
    GRIFFIN, G
    GIBSON, D
    MANDELBAUM, A
    ETINGER, A
    MECHOULAM, R
    [J]. SCIENCE, 1992, 258 (5090) : 1946 - 1949
  • [9] DEWEY WL, 1970, J PHARMACOL EXP THER, V175, P435
  • [10] ANANDAMIDE, AN ENDOGENOUS CANNABIMIMETIC EICOSANOID, BINDS TO THE CLONED HUMAN CANNABINOID RECEPTOR AND STIMULATES RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION
    FELDER, CC
    BRILEY, EM
    AXELROD, J
    SIMPSON, JT
    MACKIE, K
    DEVANE, WA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) : 7656 - 7660